Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +2.06% | +3.76% | +21.48% | -11.62% | 64.39B | |
| +0.74% | +3.52% | +51.88% | +225.16% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | 40.54B | |
| -2.36% | -1.25% | -50.98% | -58.84% | 37.98B | |
| +6.97% | +9.89% | +71.34% | -23.65% | 31.89B | |
| +12.59% | +5.18% | +147.68% | -44.25% | 26.69B | |
| +5.78% | +15.81% | +66.37% | +84.42% | 22.73B | |
| -1.25% | -1.31% | -2.84% | +151.34% | 16.66B | |
| -0.81% | +5.91% | +63.81% | +125.65% | 16.6B | |
| Average | +2.06% | +4.32% | +44.78% | +53.61% | 34.84B | |
| Weighted average by Cap. | +1.96% | +4.11% | +39.81% | +49.85% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.93M 2.7M 2.53M 4.74M 315M 4.84M 32.43M 12.55M 156M 12.54M 12.26M 540M | 6.18M 5.42M 4.99M 4.68M 8.77M 583M 8.95M 60.03M 23.23M 288M 23.21M 22.7M 999M |
| Net income | 1.4M 1.23M 1.13M 1.06M 1.99M 132M 2.03M 13.62M 5.27M 65.38M 5.27M 5.15M 227M | 2.41M 2.11M 1.95M 1.82M 3.42M 227M 3.49M 23.41M 9.06M 112M 9.05M 8.85M 390M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
